Royal Bank Of Canada Evoke Pharma Inc Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.89 - $5.75 $11 - $34
6 Added 27.27%
28 $0
Q4 2022

Feb 14, 2023
BUY
$1.44 - $2.68 $31 - $58
22 New
22 $0

Others Institutions Holding EVOK

# of Institutions
1
Shares Held
1.46K
Call Options Held
0
Put Options Held
0
View Full List

About Evoke Pharma Inc

EVOK Quotes by TradingView
  • Ticker EVOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,343,070
  • Market Cap $1.57M
  • Description
  • Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabeti...
More about EVOK
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email